USPTO Director Squires’s 2025 policies encourage more use of evidence-based SMEDs to challenge patent rejections, especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback